Chang, K.-C.; Lin, M.-T.; Wang, J.-H.; Hung, C.-H.; Chen, C.-H.; Chiu, S.Y.-H.; Hu, T.-H.
HBcrAg Predicts Hepatocellular Carcinoma Development in Chronic B Hepatitis Related Liver Cirrhosis Patients Undergoing Long-Term Effective Anti-Viral. Viruses 2022, 14, 2671.
https://doi.org/10.3390/v14122671
AMA Style
Chang K-C, Lin M-T, Wang J-H, Hung C-H, Chen C-H, Chiu SY-H, Hu T-H.
HBcrAg Predicts Hepatocellular Carcinoma Development in Chronic B Hepatitis Related Liver Cirrhosis Patients Undergoing Long-Term Effective Anti-Viral. Viruses. 2022; 14(12):2671.
https://doi.org/10.3390/v14122671
Chicago/Turabian Style
Chang, Kuo-Chin, Ming-Tsung Lin, Jing-Houng Wang, Chao-Hung Hung, Chien-Hung Chen, Sherry Yueh-Hsia Chiu, and Tsung-Hui Hu.
2022. "HBcrAg Predicts Hepatocellular Carcinoma Development in Chronic B Hepatitis Related Liver Cirrhosis Patients Undergoing Long-Term Effective Anti-Viral" Viruses 14, no. 12: 2671.
https://doi.org/10.3390/v14122671
APA Style
Chang, K.-C., Lin, M.-T., Wang, J.-H., Hung, C.-H., Chen, C.-H., Chiu, S. Y.-H., & Hu, T.-H.
(2022). HBcrAg Predicts Hepatocellular Carcinoma Development in Chronic B Hepatitis Related Liver Cirrhosis Patients Undergoing Long-Term Effective Anti-Viral. Viruses, 14(12), 2671.
https://doi.org/10.3390/v14122671